Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.

Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Torres-Granados C, Aguirre-Zamorano MA, Collantes-Estevez E, Pérez-Sánchez C.

Int J Mol Sci. 2020 Mar 16;21(6). pii: E2012. doi: 10.3390/ijms21062012. Review.

2.

Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.

Cecchi I, Perez-Sanchez C, Sciascia S, Radin M, Arias de la Rosa I, Barbarroja Puerto N, Scudeler L, Perez-Sanchez L, Patiño Trives AM, Aguirre Zamorano MA, Menegatti E, Roccatello D, Lopez-Pedrera C.

Autoimmun Rev. 2020 Apr;19(4):102488. doi: 10.1016/j.autrev.2020.102488. Epub 2020 Feb 13. No abstract available.

PMID:
32062026
3.

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.

Arias de la Rosa I, Perez-Sanchez C, Ruiz-Limon P, Patiño-Trives A, Torres-Granados C, Jimenez-Gomez Y, Abalos-Aguilera MDC, Cecchi I, Ortega R, Caracuel MA, Calvo-Gutierrez J, Escudero-Contreras A, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.

Haematologica. 2020 Jan 16. pii: haematol.2018.205047. doi: 10.3324/haematol.2018.205047. [Epub ahead of print]

4.

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion.

Pérez-Sánchez C, Cecchi I, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Pérez-Sánchez L, Ibáñez-Costa A, Arias de la Rosa I, Ortega R, Escudero A, Castro MC, Radin M, Roccatello D, Sciascia S, Aguirre MÁ, Collantes E, López-Pedrera C; BIOSAR Study Group.

J Cell Mol Med. 2019 Sep;23(9):6308-6318. doi: 10.1111/jcmm.14517. Epub 2019 Jul 26.

5.

Retraction: Evaluation of periimplant bone neoformation using different scanning electron microscope methods for measuring BIC. A dog study.

Calvo-Guirado JL, Aguilar-Salvatierra A, Guardia J, Delgado-Ruiz R, Ramírez-Fernández MP, Pérez-Sánchez C, Gómez-Moreno G.

J Clin Exp Dent. 2019 May 1;11(5):e400. doi: 10.4317/jced.56034. eCollection 2019 May.

6.

Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis.

Ruiz-Limon P, Ortega-Castro R, Barbarroja N, Perez-Sanchez C, Jamin C, Patiño-Trives AM, Luque-Tevar M, Ibáñez-Costa A, Perez-Sanchez L, de la Rosa IA, Abalos-Aguilera M, Jimenez-Gomez Y, Calvo-Gutierrez J, Font P, Escudero-Contreras A, Alarcon-Riquelme ME, Collantes-Estevez E, López-Pedrera C; PRECISESADS Clinical Consortium and Flow Cytometry Study Group.

Front Immunol. 2019 May 21;10:1111. doi: 10.3389/fimmu.2019.01111. eCollection 2019.

7.

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.

Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Collantes E, Aguirre MA, Perez-Sanchez C.

Front Immunol. 2019 Apr 16;10:764. doi: 10.3389/fimmu.2019.00764. eCollection 2019. Review.

8.

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS.

Arias de la Rosa I, Radin M, Cecchi I, Rubini E, Pérez-Sánchez C, Aguirre MÁ, Menegatti E, Barbarroja N, Collantes E, Sciascia S, Roccatello D, López Pedrera C.

Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166. No abstract available.

PMID:
31034051
9.

Clinical and radiological study of sternal fractures in pediatrics.

Moënne Bühlmann K, Araneda Castiglioni D, Ortega Flores X, Pérez Sánchez C, Escaffi Johnson J, Pérez Matta M, Godoy Lenz J.

Radiologia. 2019 May - Jun;61(3):234-238. doi: 10.1016/j.rx.2019.01.004. Epub 2019 Feb 23. English, Spanish.

10.

MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.

Aguilera-Montilla N, Bailón E, Uceda-Castro R, Ugarte-Berzal E, Santos A, Gutiérrez-González A, Pérez-Sánchez C, Van den Steen PE, Opdenakker G, García-Marco JA, García-Pardo A.

Oncogene. 2019 Jun;38(23):4605-4619. doi: 10.1038/s41388-019-0744-3. Epub 2019 Feb 13.

PMID:
30760844
11.

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Del Rio C, Cantarero I, Palomares B, Gómez-Cañas M, Fernández-Ruiz J, Pavicic C, García-Martín A, Luz Bellido M, Ortega-Castro R, Pérez-Sánchez C, López-Pedrera C, Appendino G, Calzado MA, Muñoz E.

Br J Pharmacol. 2018 Oct;175(19):3813-3831. doi: 10.1111/bph.14450. Epub 2018 Aug 23.

12.

A ketogenic diet reduces metabolic syndrome-induced allodynia and promotes peripheral nerve growth in mice.

Cooper MA, Menta BW, Perez-Sanchez C, Jack MM, Khan ZW, Ryals JM, Winter M, Wright DE.

Exp Neurol. 2018 Aug;306:149-157. doi: 10.1016/j.expneurol.2018.05.011. Epub 2018 May 17.

13.

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome.

Pérez-Sánchez C, Arias-de la Rosa I, Aguirre MÁ, Luque-Tévar M, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, Ábalos-Aguilera MC, Collantes-Estévez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martínez C, González-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, López-Pedrera C.

Haematologica. 2018 May;103(5):908-918. doi: 10.3324/haematol.2017.184416. Epub 2018 Mar 15.

14.

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues.

Arias de la Rosa I, Escudero-Contreras A, Rodríguez-Cuenca S, Ruiz-Ponce M, Jiménez-Gómez Y, Ruiz-Limón P, Pérez-Sánchez C, Ábalos-Aguilera MC, Cecchi I, Ortega R, Calvo J, Guzmán-Ruiz R, Malagón MM, Collantes-Estevez E, Vidal-Puig A, López-Pedrera C, Barbarroja N.

J Intern Med. 2018 Jul;284(1):61-77. doi: 10.1111/joim.12743. Epub 2018 Mar 12.

PMID:
29532531
15.

Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.

Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, Lopez-Pedrera C, Castro-Villegas MC, Abalos-Aguilera MC, Barbarroja N, Arias-de la Rosa I, Lopez-Montilla MD, Escudero-Contreras A, Lopez-Medina C, Collantes-Estevez E, Jimenez-Gomez Y.

Hum Mol Genet. 2018 Mar 1;27(5):875-890. doi: 10.1093/hmg/ddy008.

PMID:
29329380
16.

Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.

Pérez-Sánchez C, Aguirre MÁ, Ruiz-Limón P, Ábalos-Aguilera MC, Jiménez-Gómez Y, Arias-de la Rosa I, Rodriguez-Ariza A, Fernández-Del Río L, González-Reyes JA, Segui P, Collantes-Estévez E, Barbarroja N, Velasco F, Sciascia S, Cecchi I, Cuadrado MJ, Villalba JM, López-Pedrera C.

Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1923-1932. doi: 10.1161/ATVBAHA.117.309225. Epub 2017 Jul 6.

PMID:
28684614
17.

Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.

Lopez-Pedrera C, Aguirre-Zamorano MÁ, Pérez-Sánchez C.

Med Clin (Barc). 2017 Aug 22;149(4):160-169. doi: 10.1016/j.medcli.2017.05.003. Epub 2017 Jun 12. Review. English, Spanish.

PMID:
28619369
18.

Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?

Radin M, Cecchi I, Pérez-Sánchez C.

Lupus. 2017 Nov;26(13):1457-1458. doi: 10.1177/0961203317711014. Epub 2017 May 22. No abstract available.

PMID:
28530465
19.

Regulated Intron Removal Integrates Motivational State and Experience.

Gill J, Park Y, McGinnis JP, Perez-Sanchez C, Blanchette M, Si K.

Cell. 2017 May 18;169(5):836-848.e15. doi: 10.1016/j.cell.2017.05.006.

20.

Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.

Pérez-Sánchez C, Ruiz-Limón P, Aguirre MA, Jiménez-Gómez Y, Arias-de la Rosa I, Ábalos-Aguilera MC, Rodriguez-Ariza A, Castro-Villegas MC, Ortega-Castro R, Segui P, Martinez C, Gonzalez-Conejero R, Rodríguez-López S, Gonzalez-Reyes JA, Villalba JM, Collantes-Estévez E, Escudero A, Barbarroja N, López-Pedrera C.

J Autoimmun. 2017 Aug;82:31-40. doi: 10.1016/j.jaut.2017.04.007. Epub 2017 Apr 29.

PMID:
28465139
21.

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.

B Arroyo A, Salloum-Asfar S, Pérez-Sánchez C, Teruel-Montoya R, Navarro S, García-Barberá N, Luengo-Gil G, Roldán V, Hansen JB, López-Pedrera C, Vicente V, González-Conejero R, Martínez C.

Sci Rep. 2017 Feb 27;7:43500. doi: 10.1038/srep43500.

22.

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

Ruiz-Limón P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MDC, Perez-Sanchez C, Jimenez-Gomez Y, Peralbo-Santaella E, Font P, Ruiz-Vilches D, Ferrin G, Collantes-Estevez E, Escudero-Contreras A, López-Pedrera C, Barbarroja N.

Transl Res. 2017 May;183:87-103. doi: 10.1016/j.trsl.2016.12.003. Epub 2016 Dec 9.

PMID:
28027930
23.

'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'.

Pérez-Sánchez C, Aguirre MA, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, de la Rosa IA, Rodriguez-Ariza A, Collantes-Estévez E, Segui P, Velasco F, Cuadrado MJ, Teruel R, González-Conejero R, Martínez C, López-Pedrera Ch.

Sci Rep. 2016 Aug 9;6:31375. doi: 10.1038/srep31375.

24.

Amyloidogenic Oligomerization Transforms Drosophila Orb2 from a Translation Repressor to an Activator.

Khan MR, Li L, Pérez-Sánchez C, Saraf A, Florens L, Slaughter BD, Unruh JR, Si K.

Cell. 2015 Dec 3;163(6):1468-83. doi: 10.1016/j.cell.2015.11.020.

25.

Immunotherapy in antiphospholipid syndrome.

Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ.

Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Epub 2015 Jun 15. Review.

PMID:
26086363
26.

A Monte Carlo-Based Bayesian Approach for Measuring Agreement in a Qualitative Scale.

Calle-Alonso F, Pérez Sánchez CJ.

Appl Psychol Meas. 2015 May;39(3):189-207. doi: 10.1177/0146621614554080. Epub 2014 Nov 5.

27.

Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.

Castro-Villegas C, Pérez-Sánchez C, Escudero A, Filipescu I, Verdu M, Ruiz-Limón P, Aguirre MA, Jiménez-Gomez Y, Font P, Rodriguez-Ariza A, Peinado JR, Collantes-Estévez E, González-Conejero R, Martinez C, Barbarroja N, López-Pedrera C.

Arthritis Res Ther. 2015 Mar 9;17:49. doi: 10.1186/s13075-015-0555-z.

28.

Human mesenchymal stromal cell lysates as a novel strategy to recover liver function.

Herencia C, Almadén Y, Martínez-Moreno JM, Espejo I, Herrera C, Pérez-Sánchez C, Guerrero F, Ciria R, Briceño FJ, Ferrín G, de la Mata M, Muñoz-Castañeda JR.

Regen Med. 2015;10(1):25-38. doi: 10.2217/rme.14.59.

PMID:
25562350
29.

Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis.

Barbarroja N, Pérez-Sanchez C, Ruiz-Limon P, Castro-Villegas C, Aguirre MA, Carretero R, Segui P, Jimenez-Gomez Y, Sanna M, Rodriguez-Ariza A, Collantes-Estevez E, Escudero A, López-Pedrera C.

Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2706-16. doi: 10.1161/ATVBAHA.114.304475. Epub 2014 Sep 25.

PMID:
25256232
30.

Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.

Ruiz-Limon P, Barbarroja N, Perez-Sanchez C, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Almadén Y, Segui P, Khraiwesh H, Gonzalez-Reyes JA, Villalba JM, Collantes-Estevez E, Cuadrado MJ, Lopez-Pedrera C.

Ann Rheum Dis. 2015 Jul;74(7):1450-8. doi: 10.1136/annrheumdis-2013-204351. Epub 2014 Mar 21.

PMID:
24658835
31.

Role of glutamate receptors of central and basolateral amygdala nuclei on retrieval and reconsolidation of taste aversive memory.

Garcia-Delatorre P, Pérez-Sánchez C, Guzmán-Ramos K, Bermúdez-Rattoni F.

Neurobiol Learn Mem. 2014 May;111:35-40. doi: 10.1016/j.nlm.2014.03.003. Epub 2014 Mar 13.

PMID:
24631645
32.

Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.

Perez-Sanchez C, Barbarroja N, Messineo S, Ruiz-Limon P, Rodriguez-Ariza A, Jimenez-Gomez Y, Khamashta MA, Collantes-Estevez E, Cuadrado MJ, Aguirre MA, Lopez-Pedrera C.

Ann Rheum Dis. 2015 Jul;74(7):1441-9. doi: 10.1136/annrheumdis-2013-204600. Epub 2014 Mar 11.

PMID:
24618261
33.

Molecular diagnosis of endometrial cancer from uterine aspirates.

Perez-Sanchez C, Colas E, Cabrera S, Falcon O, Sanchez-del-Río A, García E, Fernández-de-Castillo L, Muruzabal JC, Alvarez E, Fiol G, González C, Torrejón R, Moral E, Campos M, Repollés M, Carreras R, Jiménez-López J, Xercavins J, Aibar E, Perdones-Montero A, Lalanne E, Palicio M, Maes T, Rosell-Vives E, Nieto C, Ortega A, Pedrola N, Llauradó M, Rigau M, Doll A, Abal M, Ponce J, Gil-Moreno A, Reventós J.

Int J Cancer. 2013 Nov 15;133(10):2383-91. doi: 10.1002/ijc.28243. Epub 2013 Jun 21.

34.

Three molecular classifications surrogate to four immunohistochemical markers in 374 invasive breast carcinomas with long follow-up: which is better?

Ruiz Martín J, Pérez Sánchez C, de las Heras Camino A.

Pathol Res Pract. 2013 Jun;209(6):337-44. doi: 10.1016/j.prp.2013.03.003. Epub 2013 Mar 21.

PMID:
23582367
35.

Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment.

Perez-Sanchez C, Ruiz-Limon P, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Segui P, Collantes-Estevez E, Barbarroja N, Khraiwesh H, Gonzalez-Reyes JA, Villalba JM, Velasco F, Cuadrado MJ, Lopez-Pedrera C.

Blood. 2012 Jun 14;119(24):5859-70. doi: 10.1182/blood-2011-12-400986. Epub 2012 Apr 23.

PMID:
22529290
36.

Evaluation of periimplant bone neoformation using different scanning electron microscope methods for measuring BIC. A dog study.

Calvo-Guirado JL, Aguilar-Salvatierra A, Guardia J, Delgado-Ruiz R, Ramírez-Fernández MP, Pérez Sánchez C, Gómez-Moreno G.

J Clin Exp Dent. 2012 Feb 1;4(1):e8-e13. doi: 10.4317/jced.50624. eCollection 2012 Feb. Retraction in: J Clin Exp Dent. 2019 May 1;11(5):e400.

37.

Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.

López-Pedrera C, Pérez-Sánchez C, Ramos-Casals M, Santos-Gonzalez M, Rodriguez-Ariza A, Cuadrado MJ.

Clin Dev Immunol. 2012;2012:974648. doi: 10.1155/2012/974648. Epub 2011 Sep 14. Review.

38.

Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome.

Teruel R, Pérez-Sánchez C, Corral J, Herranz MT, Pérez-Andreu V, Saiz E, García-Barberá N, Martínez-Martínez I, Roldán V, Vicente V, López-Pedrera C, Martínez C.

J Thromb Haemost. 2011 Oct;9(10):1985-92. doi: 10.1111/j.1538-7836.2011.04451.x.

39.

Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.

López-Pedrera C, Ruiz-Limón P, Aguirre MÁ, Barbarroja N, Pérez-Sánchez C, Buendía P, Rodriguez-García IC, Rodriguez-Ariza A, Collantes-Estevez E, Velasco F, Khasmahta M, Cuadrado MJ.

Ann Rheum Dis. 2011 Apr;70(4):675-82. doi: 10.1136/ard.2010.135525. Epub 2010 Dec 20.

PMID:
21173016
40.

AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.

Barbarroja N, Torres LA, Rodriguez-Ariza A, Valverde-Estepa A, Lopez-Sanchez LM, Ruiz-Limon P, Perez-Sanchez C, Carretero RM, Velasco F, López-Pedrera C.

Exp Hematol. 2010 Aug;38(8):641-52. doi: 10.1016/j.exphem.2010.03.017. Epub 2010 Apr 7.

PMID:
20380868
41.

Biomaterials for bone regeneration.

Pérez-Sánchez MJ, Ramírez-Glindon E, Lledó-Gil M, Calvo-Guirado JL, Pérez-Sánchez C.

Med Oral Patol Oral Cir Bucal. 2010 May 1;15(3):e517-22. Review.

42.

Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.

Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R.

Nat Cell Biol. 2009 Mar;11(3):257-68. doi: 10.1038/ncb1833. Epub 2009 Feb 8.

43.

Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.

Budhram-Mahadeo VS, Bowen S, Lee S, Perez-Sanchez C, Ensor E, Morris PJ, Latchman DS.

Nucleic Acids Res. 2006;34(22):6640-52. Epub 2006 Dec 1.

44.

[Laryngeal actinomycosis].

García Lozano MC, Pérez Sánchez C, Ayala Martínez L.

An Otorrinolaringol Ibero Am. 2004;31(3):237-44. Review. Spanish.

PMID:
15259846
45.

Prenatal diagnosis of an interstitial 12q chromosome deletion.

Pérez Sánchez C, Ayensa F, Lloveras E, Zamora L, Cirigliano V, Pérez E, Plaja A.

Ann Genet. 2004 Apr-Jun;47(2):177-9.

PMID:
15183750
46.
47.

DmFoxF, a novel Drosophila fork head factor expressed in visceral mesoderm.

Pérez Sánchez C, Casas-Tintó S, Sánchez L, Rey-Campos J, Granadino B.

Mech Dev. 2002 Feb;111(1-2):163-6.

48.

Comparison of two clinical scales for causality assessment in hepatotoxicity.

Lucena MI, Camargo R, Andrade RJ, Perez-Sanchez CJ, Sanchez De La Cuesta F.

Hepatology. 2001 Jan;33(1):123-30.

PMID:
11124828
49.

Fhx (Foxj2) expression is activated during spermatogenesis and very early in embryonic development.

Granadino B, Arias-de-la-Fuente C, Pérez-Sánchez C, Párraga M, López-Fernández LA, del Mazo J, Rey-Campos J.

Mech Dev. 2000 Oct;97(1-2):157-60.

50.

FHX.L and FHX.S, two isoforms of the human fork-head factor FHX (FOXJ2) with differential activity.

Pérez-Sánchez C, Arias-de-la-Fuente C, Gómez-Ferrería MA, Granadino B, Rey-Campos J.

J Mol Biol. 2000 Aug 25;301(4):795-806.

PMID:
10966786

Supplemental Content

Loading ...
Support Center